1-8 of 8
Eric M. Ostertag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control

Hubert Tseng, Yan Zhang, Stacey A Cranert, Maximilian Richter, Karl Marquez, Jing Qiu, Benjamin Cho, Yening Tan, Min Tong, Christine Domingo, Leslie Weiss, Elvira Argus, Jessica Sparks, Eric M. Ostertag, Julia Coronella, Devon J Shedlock
Journal: Blood
Blood (2021) 138 (Supplement 1): 4802.
https://doi.org/10.1182/blood-2021-154034
Published: 2021
Journal Articles

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet Hakan Kocoglu, Abhinav Deol, Abbas Abbas Ali, Tara Gregory, Bhagirathbhai Dholaria, Jesus G Berdeja, Adam D Cohen, Krina K. Patel, David S. Siegel, Rajneesh Nath, Katherine McArthur, Joanne McCaigue, Christopher E Martin, Majid Ghoddusi, Hamid Namini, Eric M. Ostertag, Matthew A. Spear, Rajesh Belani, Nina Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 3858.
https://doi.org/10.1182/blood-2021-151672
Published: 2021
Journal Articles

Phase 1/2 Study of the Safety and Response of P-BCMA-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME) with Novel Therapeutic Strategies

Caitlin L. Costello, MD, Adam D. Cohen, MD, Krina K. Patel, MD, Syed S Ali, MD, Jesus G. Berdeja, MD, Nina Shah, MD, Siddhartha Ganguly, MD, Mehmet Hakan Kocoglu, MD, Mehrdad Abedi, MD, Eric M. Ostertag, MD PhD, Chris E Martin, PhD, Majid Ghoddussi, PhD, Devon J Shedlock, PhD, Joanne McCaigue, M.S., Hamid Namini, PhD, Sreeni Yalamanchili, Matthew A. Spear, MD, Tara K. Gregory, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-142695
Published: 2020
Journal Articles

Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable

Stacey A Cranert, PhD, Maximilian Richter, PhD, Min Tong, MS, Leslie Weiss, MS, Yening Tan, MS, Eric M. Ostertag, MD PhD, Julia Coronella, PhD, Devon J Shedlock, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4445.
https://doi.org/10.1182/blood-2019-131839
Published: 2019
Journal Articles

Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Tara Gregory, MD, Adam D. Cohen, MD, Caitlin L. Costello, MD, Syed Abbas Ali, MD, Jesus G. Berdeja, MD, Eric M Ostertag, MD PhD, Christopher Martin, PhD, Devon J Shedlock, PhD, Michelle Lynn Resler, BS, Matthew A. Spear, MD, Robert Z. Orlowski, MD PhD, Krina K. Patel, MDMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1012.
https://doi.org/10.1182/blood-2018-99-111419
Published: 2018
Journal Articles

B-Cell Maturation Antigen (BCMA)-Specific, Centyrin TM -Based, PiggyBac TM -Transposed CAR-T Memory Stem Cells Are Effective Against p53 -/- and Patient-Derived Multiple Myeloma Tumors

Rohit Mathur, PhD, Burton Earle Barnett, PhD, David Hermanson, PhD, Jin He, Zheng Zhang, Srinivas Rengarajan, MS, Rebecca Codde, Xinxin Wang, PhD, Yening Tan, Christopher Martin, Jenessa Smith, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Krina K. Patel, MDMSc, Donna M. Weber, MD, R. Eric Davis, MD, Robert Z. Orlowski, MD PhD, Eric M Ostertag, Devon Shedlock, PhD, Jing Yang, PhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3068.
https://doi.org/10.1182/blood.V130.Suppl_1.3068.3068
Published: 2017
Journal Articles

Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma

Xinxin Wang, PhD, Burton Earle Barnett, PhD, Christopher Martin, David Hermanson, PhD, Xianghong Li, Jenessa Smith, Joann Wu, Stacey Cranert, PhD, Srinivas Rengarajan, MS, Yening Tan, Min Tong, Rebecca Codde, Julian D Down, Eric M Ostertag, Devon J Shedlock
Journal: Blood
Blood (2017) 130 (Supplement 1): 503.
https://doi.org/10.1182/blood.V130.Suppl_1.503.503
Published: 2017
Journal Articles

The Application of ‘Drug-Reversible’ CAR-T Cells Directed Against Recipient Hematopoietic Cells As a Selective Conditioning Strategy for Stem Cell Transplantation

Nina Timberlake, Maximilian Richter, Xinxin Wang, PhD, Nicholas Cam, Yening Tan, Eric M Ostertag, Devon J Shedlock, Julian D Down
Journal: Blood
Blood (2017) 130 (Supplement 1): 1893.
https://doi.org/10.1182/blood.V130.Suppl_1.1893.1893
Published: 2017